David Richman

image of David Richman

Professor of Medical Neurology

Departments

Neurology - Medicine

Offices and Labs

510 1515 Newton Court
754-5013

Degrees

1969 MD Johns Hopkins School of Medicine
1965 BA Mathematics Princeton University

Department and Center Affiliations

Department of Neurology
Center for Neuroscience

ProfessionalSocieties

American Neurologic Association
American Association of Immunologists

CBS Grad Group Affiliations

Neuroscience
Molecular, Cellular, and Integrative Physiology

Specialties / Focus

Molecular, Cellular, and Integrative Physiology
  • Neurophysiology

Publications

5/21/2010 9:26:34 AM
  • Mihovilovic, M., Donnelly-Roberts, D., Richman, D.P. and Martinez-Carrion, M. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. J. Immunol. 152:5997-6002, 1994. Richman, D.P., Ed. Myasthenia Gravis and Related Diseases: Disorders of the Neuromuscular Junction. New York Academy of Sciences (Annals V. 841), New York, 838 pp., 1998. Fairclough, R.H., Twaddle, G.M., Gudipati, E., Richman, D.P., Burkwall, D.A., and Josephs R. Mapping the mAb 383C epitope to alpha(187-199) of the Torpedo acetylcholine receptor on the three dimensional model. J. Mol. Biol. 282:301-315, 1998. Fairclough, R.H., Twaddle, G.M., Gudipati, E., Lin, M.Y. and Richman, D.P. Differential surface accessibility of alpha(187-199) in the Torpedo acetylcholine receptor alpha subunits. J. Mol. Biol. 282:317-330, 1998. Maselli, R.A., Kong, D., Bowe, C., McDonald, C., Ellis, W., Agius, M.A., Gomez, C.M., Richman, D.P., and Wollmann, R.L. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology 57: 279-289, 2001. Richman, D.P. and Agius, M.A. Treatment of autoimmune myasthenia gravis. Neurology. (in press). Fairclough, R.H., Agius, M.A., Gudipati, E., Silvian, L., Hamaoka, B., Beltzer, C.C., Lin, M.Y., Chuang, A. and Richman, D.P. Agonist induced transitions of the acetylcholine receptor. Ann NY Acad Sci (in press).